What is Chase-Logeman?
Chase-Logeman Corporation is a distinguished manufacturer of precision filling machinery, with a particular expertise in Monoblock-style equipment. Serving a diverse range of sectors including pharmaceutical, diagnostic, healthcare, food, industrial, and wellness, the company leverages over six decades of experience. Chase-Logeman is recognized for its dependable and easily validated machines, designed for both simplicity and enduring performance. Their comprehensive product portfolio encompasses fully and semi-automatic filling systems, alongside integrated capabilities for capping, labeling, and vial handling. This dedication to superior quality and continuous innovation solidifies Chase-Logeman as a premier partner for enterprises aiming to optimize their filling operations.
How much funding has Chase-Logeman raised?
Chase-Logeman has raised a total of $341K across 2 funding rounds:
Debt
$150K
Debt
$191K
Debt (2020): $150K with participation from PPP
Debt (2021): $191K led by PPP
What's next for Chase-Logeman?
The substantial late-stage funding Chase-Logeman has received signals a strategic phase of growth and potential expansion. This capital infusion is likely to fuel advancements in their manufacturing capabilities, research and development for next-generation machinery, and potentially broaden their market reach. As a company with a long-standing reputation for reliability and precision, this investment will enable Chase-Logeman to further solidify its leadership in the competitive filling machinery sector and capitalize on emerging opportunities within its target industries.
See full Chase-Logeman company page
